See All Slides - tctmd.com

Slides

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Long-term Patency Is Essential Following BTK Intervention for Limb Salvage!

Presenter: Thomas Zeller

October 28, 2013

Presentation TCT 2013

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

Presenter: Hyo-Soo Kim

October 28, 2013

Presentation TCT 2013

Everything You Wanted to Know About the Carina but Were Afraid to Ask: Carina Atherosclerosis, Shift, and Implications for a Provisional Strategy

Presenter: Akiko Maehara

October 28, 2013

Presentation TCT 2013

FFR is Physiologic, and We Have the Data!

Presenter: Michalis Hamilos

October 28, 2013

Presentation TCT 2013

It Is Time to Scale Back to Three to Six Months!

Presenter: Fausto Feres

October 28, 2013

Presentation TCT 2013

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Presenter: Christoph Naber

October 28, 2013

Presentation TCT 2013

Ischemic vs Idiopathic Functional MR: Differences in Pathophysiology, Prognosis and Response to Therapies

Presenter: Blase Carabello

October 28, 2013

Presentation TCT 2013

Planned 2-stent Technique Case Presentation Case #4: V-Stent or SKS

Presenter: David Rizik

October 28, 2013

Advertisement

Slides

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Do I Really Need Bioresorbable Scaffolds in Germany?

Long-term Patency Is Essential Following BTK Intervention for Limb Salvage!

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

Everything You Wanted to Know About the Carina but Were Afraid to Ask: Carina Atherosclerosis, Shift, and Implications for a Provisional Strategy

FFR is Physiologic, and We Have the Data!

It Is Time to Scale Back to Three to Six Months!

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Ischemic vs Idiopathic Functional MR: Differences in Pathophysiology, Prognosis and Response to Therapies

Planned 2-stent Technique Case Presentation Case #4: V-Stent or SKS

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content